Shay Capital’s Celularity CELU Stock Holding History

Shay Capital’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-143,414	Closed	-$14.5M	–	539
2021 Q1	$14.5M	Buy	143,414 +56,602	+65%	+$5.8M	1.47%	15
2020 Q4	$9.55M	Buy	+86,812	New	+$9.23M	2.08%	11

Other funds holding CELU

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Shay Capital's CELU Position: Q2 2021 in Review

Shay Capital sold out of Celularity (CELU) in Q2 2021, closing a stake of 143,414 shares — an estimated $14.5M sold.

Shay Capital first reported a position in CELU in Q4 2020 and held it in 2 quarters. The position peaked at $14.5M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

Shay Capital reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
Shay Capital sold 143,414 Celularity shares in Q2 2021, an estimated $14.5M.
Shay Capital first reported a position in Celularity in Q4 2020 and held it in 2 quarters.
Shay Capital's Celularity position peaked at $14.5M in Q1 2021.
33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on Shay Capital's 13F filing for Q2 2021, filed 13 Aug 2021.